How a migraine prevention medication works in the brain and body

This research study is investigating how atogepant, an oral medication designed to prevent migraines, works in your brain and body. Researchers want to understand the biological pathways that the medication affects—not just whether it reduces migraine days, but *how* it does so. This knowledge could help doctors predict which patients will benefit most from this treatment and improve personalized migraine care.

While this medication is effective for many people with frequent episodic migraines, about 30% of patients don't respond well enough to treatment. This suggests that other biological systems beyond the main pathway the medication targets may be involved in migraines. By studying how the medication works at a deeper level, researchers hope to unlock better treatment options for people who don't respond to current approaches.